Literature DB >> 32068938

Hypoperfusion intensity ratio correlates with angiographic collaterals in acute ischaemic stroke with M1 occlusion.

A Guenego1, R Fahed2, G W Albers3, G Kuraitis1, E S Sussman1, B W Martin1, D G Marcellus1, J-M Olivot4, M P Marks1, M G Lansberg3, M Wintermark1, J J Heit1.   

Abstract

BACKGROUND AND
PURPOSE: Among patients with an acute ischaemic stroke secondary to large-vessel occlusion, the hypoperfusion intensity ratio (HIR) [time to maximum (TMax) > 10 volume/TMax > 6 volume] is a strong predictor of infarct growth. We studied the correlation between HIR and collaterals assessed with digital subtraction angiography (DSA) before thrombectomy.
METHODS: Between January 2014 and March 2018, consecutive patients with an acute ischaemic stroke and an M1 middle cerebral artery (MCA) occlusion who underwent perfusion imaging and endovascular treatment at our center were screened. Ischaemic core (mL), HIR and perfusion mismatch (TMax > 6 s minus core volume) were assessed through magnetic resonance imaging or computed tomography perfusion. Collaterals were assessed on pre-intervention DSA using the American Society of Interventional and Therapeutic Neuroradiology/Society of Interventional Radiology (ASITN/SIR) scale. Baseline clinical and perfusion characteristics were compared between patients with good (ASITN/SIR score 3-4) and those with poor (ASITN/SIR score 0-2) DSA collaterals. Correlation between HIR and ASITN/SIR scores was evaluated using Pearson's correlation. Receiver operating characteristic analysis was performed to determine the optimal HIR threshold for the prediction of good DSA collaterals.
RESULTS: A total of 98 patients were included; 49% (48/98) had good DSA collaterals and these patients had significantly smaller hypoperfusion volumes (TMax > 6 s, 89 vs. 125 mL; P = 0.007) and perfusion mismatch volumes (72 vs. 89 mL; P = 0.016). HIR was significantly correlated with DSA collaterals (-0.327; 95% confidence interval, -0.494 to -0.138; P = 0.01). An HIR cut-off of <0.4 best predicted good DSA collaterals with an odds ratio of 4.3 (95% confidence interval, 1.8-10.1) (sensitivity, 0.792; specificity, 0.560; area under curve, 0.708).
CONCLUSION: The HIR is a robust indicator of angiographic collaterals and might be used as a surrogate of collateral assessment in patients undergoing magnetic resonance imaging. HIR <0.4 best predicted good DSA collaterals.
© 2020 European Academy of Neurology.

Entities:  

Keywords:  collateral circulation; perfusion imaging; stroke; thrombectomy

Mesh:

Year:  2020        PMID: 32068938     DOI: 10.1111/ene.14181

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  14 in total

Review 1.  Collateral Blood Flow and Ischemic Core Growth.

Authors:  Kimberly Seifert; Jeremy J Heit
Journal:  Transl Stroke Res       Date:  2022-06-14       Impact factor: 6.829

2.  A Glutamate N-Methyl-d-Aspartate (NMDA) Receptor Subunit 2B-Selective Inhibitor of NMDA Receptor Function with Enhanced Potency at Acidic pH and Oral Bioavailability for Clinical Use.

Authors:  Scott J Myers; Kamalesh P Ruppa; Lawrence J Wilson; Yesim A Tahirovic; Polina Lyuboslavsky; David S Menaldino; Zackery W Dentmon; George W Koszalka; Robert Zaczek; Raymond J Dingledine; Stephen F Traynelis; Dennis C Liotta
Journal:  J Pharmacol Exp Ther       Date:  2021-09-07       Impact factor: 4.402

3.  RAPID CT Perfusion-Based Relative CBF Identifies Good Collateral Status Better Than Hypoperfusion Intensity Ratio, CBV-Index, and Time-to-Maximum in Anterior Circulation Stroke.

Authors:  A Potreck; E Scheidecker; C S Weyland; U Neuberger; C Herweh; M A Möhlenbruch; M Chen; S Nagel; M Bendszus; F Seker
Journal:  AJNR Am J Neuroradiol       Date:  2022-06-09       Impact factor: 4.966

4.  Prognostic Accuracy of CTP Summary Maps in Patients with Large Vessel Occlusive Stroke and Poor Revascularization after Mechanical Thrombectomy-Comparison of Three Automated Perfusion Software Applications.

Authors:  Iris Muehlen; Matthias Borutta; Gabriela Siedler; Tobias Engelhorn; Stefan Hock; Michael Knott; Philip Hoelter; Bastian Volbers; Stefan Schwab; Arnd Doerfler
Journal:  Tomography       Date:  2022-05-17

5.  Cerebral Circulation Time After Thrombectomy: A Potential Predictor of Outcome After Recanalization in Acute Stroke.

Authors:  Jia-Qi Wang; Ying-Jia Wang; Jin Qiu; Wei Li; Xian-Hui Sun; Yong-Gang Zhao; Xin Liu; Zi-Ai Zhao; Liang Liu; Thanh N Nguyen; Hui-Sheng Chen
Journal:  J Am Heart Assoc       Date:  2022-05-27       Impact factor: 6.106

6.  Susceptibility-diffusion mismatch correlated with leptomeningeal collateralization in large vessel occlusion stroke.

Authors:  Haifei Jiang; Yiqun Zhang; Jiangxia Pang; Chaojie Shi; Ao-Fei Liu; Chen Li; Min Jin; Fengyuan Man; Wei-Jian Jiang
Journal:  J Int Med Res       Date:  2021-05       Impact factor: 1.671

7.  Association of CT-Based Hypoperfusion Index With Ischemic Core Enlargement in Patients With Medium and Large Vessel Stroke.

Authors:  Ali Z Nomani; Joseph Kamtchum Tatuene; Jeremy L Rempel; Thomas Jeerakathil; Ian R Winship; Khurshid A Khan; Brian H Buck; Ashfaq Shuaib; Glen C Jickling
Journal:  Neurology       Date:  2021-10-04       Impact factor: 9.910

8.  Effect of Sex on Clinical Outcome and Imaging after Endovascular Treatment of Large-Vessel Ischemic Stroke.

Authors:  Jelle Demeestere; Sören Christensen; Michael Mlynash; Christian Federau; Gregory W Albers; Robin Lemmens; Maarten G Lansberg
Journal:  J Stroke Cerebrovasc Dis       Date:  2020-11-21       Impact factor: 2.136

9.  Predictors of Early and Late Infarct Growth in DEFUSE 3.

Authors:  William J Tate; Laura C Polding; Søren Christensen; Michael Mlynash; Stephanie Kemp; Jeremy J Heit; Michael P Marks; Gregory W Albers; Maarten G Lansberg
Journal:  Front Neurol       Date:  2021-07-01       Impact factor: 4.003

10.  Hypoperfusion Intensity Ratio Correlates with CTA Collateral Status in Large-Vessel Occlusion Acute Ischemic Stroke.

Authors:  D Lyndon; M van den Broek; B Niu; S Yip; A Rohr; F Settecase
Journal:  AJNR Am J Neuroradiol       Date:  2021-06-17       Impact factor: 4.966

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.